BAT ready to invest tax savings in HnB and e-cigs
1st March 2018 | News analysis |
British American Tobacco (BAT) has announced it will invest half the money it has saved from US corporate tax restructuring in next generation products
British American Tobacco (BAT) has announced it will invest half the money it has saved from US corporate tax restructuring in next generation products
The US FDA recognises flavoured e-liquids may help encourage smokers to switch to e-cigs, despite its hostility to flavours in most tobacco products, commissioner Scott Gottlieb told the Society for Research on Nicotine & Tobacco (SRNT)
The US FDA has made some public amendments to PMI’s reduced risk applications for IQOS and three types of Marlboro HeatSticks products
The federal health minister for Canada has called for “clear restrictions” on e-cigarette advertising and the need to keep young people from taking up e-cigs. The move is a turnaround from the stance of the previous health minister.
British American Tobacco claims to be the largest reduced-risk product company in the world following its acquisition of Reynolds American and says it will build on this through a variety of HnB, moist tobacco and oral tobacco brands
Top executives of Philip Morris International (PMI) have promised at a major US analysts’ conference to make the raw data from clinical and non-clinical studies for the company’s reduced risk products available to the public later this year
The most common reason that youth used e-cigs in the US in 2016 was that a friend or family member used them, according to information from the National Youth Survey for 2016, analysis of which was recently published by the Center for Disease Control and Prevention (CDC). The second most-prevalent was the availability of flavours.
The libertarian Pacific Legal Foundation (PLF) has brought a series of suits from vape stores across the US to several federal district courts, alleging that the FDA’s deeming rule violates the US Constitution
Ten US Senators have urged the FDA to reject PMI’s reduced risk application for IQOS following the findings of the independent Tobacco Products Scientific Advisory Committee (TPSAC)
The furore stirred up last year by the news agency Reuters’ coverage of Philip Morris International (PMI) has now died down, but it may have impacted on the company in three distinct ways
The abrupt resignation of Brenda Fitzgerald as director of the Centers for Disease Control and Prevention could provide the Trump administration with an unexpected opportunity to help settle a question on the agency’s anti-tobacco efforts
A widely publicised New York report concludes that e-cig “smoke…may contribute to lung and bladder cancer, as well as heart disease, in humans” – but other scientists question the validity of research carried out on laboratory mice
The US government has been given an ‘F’ grade by the American Lung Association for its federal tobacco regulations and taxation policies, blaming its “partial implementation” of the Tobacco Control Act
The Hawaiian senate is considering two bills, which could prohibit online sales of e-cigarette products if passed. One could also subject e-liquids to the same excise tax as tobacco products.
A report by the US National Academies of Sciences, Engineering, and Medicine (NASEM) presents a long list of suggestions for research into the public health consequences of e-cigarettes
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
Questions over dual use and whether menthol flavours would attract at-risk groups led the start of the long-awaited Food and Drug Administration (FDA) hearing for Philip Morris International (PMI)’s modified risk claim for its IQOS heated-tobacco product
Scrapping the old “for tobacco only” message, companies developing vaping gear have found it easier to raise capital for cannabis-based ventures than for those based on e-cigarettes or tobacco
An independent report commissioned by the FDA to evaluate the evidence for the health effects of e-cigarettes has come back with a mix of good and bad news for the industry and produced headlines around the US
Congressman Tom Cole insists he has not given up his effort to bring legislative relief to the e-cigarette industry despite the tribulations of the latest US government shutdown
FDA oversight of the tobacco and e-cig industry looks likely to be virtually unaffected by the shutdown of US government functions as it continues to operate on fees paid by the industry
A new analysis of smoking’s effects on the human body, undertaken by scientists associated with PMI, illustrates some of the difficulties in establishing whether an alternative nicotine product really reduces risk
As the US FDA gets to grips with its new focus on nicotine as a single marketplace, it is planning to take a fresh look at one of the longest-established non-combustible forms of the substance – nicotine replacement therapy
ECigIntelligence managing director Tim Phillips will be among speakers at a US symposium next month on vapour, tobacco and the law, including topics such as taxation, intellectual property and advertising
A widely publicised report by researchers at the University of California, San Francisco claims to show that vaping leads young people in the US to smoking
A clinical trial among homeless people in Canada raises an intriguing question: could governments supply e-cigarettes free as a public health tool? And indeed, should they?
US Representative Tom Cole is still hoping his bid to bring relief to the e-cigarette industry will make it into a major federal spending bill and onto President Trump’s desk
Opinions on tobacco are strongly coloured by political orientation, new European research suggests – while a US study finds it also affects whether people trust industry or health experts more
R. J. Reynolds has submitted modified risk tobacco product applications (MRTPAs) to the US FDA for six forms of its Camel Snus product, which it is seeking to market as reducing the risk of specific smoking-related diseases
An Ontario law which will impose further restrictions on e-cigarettes in the Canadian province – notably a rather vaguely worded ban on flavours – has received royal assent
Get 7 days of FREE platform access: Demo our data contents without commitment